mode of pest control for these farmers. Organic farmers and others who rely on Bt
question whether the companies who sell the Bt crops have the right to use up this
resource guided only by commercial calculations. UCS considers Bt to be a public
good that should be reserved for everyone.
Virus Tolerance
The third major application of biotechnology to crops is virus tolerance. These crops
contain a gene taken from a virus. By a process that is not well understood, plants
that produce certain viral proteins are able to fend off infections by the viruses from
which the proteins were taken. Two virus-tolerant crops are currently approved for
commercial use, papaya and squash. The squash, which is resistant to two viruses,
is currently off the market. Although it is difficult to get information on why products
are not on the market, it is possible that the squash did not perform well enough in
the field to capture market share.
Other Engineered Products
Many other genetically engineered products have been envisioned, but only a few
have so far come to market.
Several tomatoes engineered to delay ripening have been approved for commercial
use. In some cases, delayed ripening just prolongs shelf life. But for the
FlavrSavrTM, the objective was to increase the time on the vine without softening,
producing a transportable, tasty winter tomato. After a highly publicized rollout, the
FlavrSavrTM too is off the market. The problem appears to have been with
transportability rather than taste.
On the livestock side, a drug has been produced for dairy cowsrecombinant
Bovine Growth Hormone (BGH) or Bovine Somatotropin (BST)by engineering a
bacterium to contain the gene for the hormone. The drug is administered to cows to
increase milk production, despite the chronic oversupply of milk in the United
States. A highly controversial product, BGH is currently used on about a third of the
U.S. dairy herd.
An interesting product not related to agriculture is a rabies vaccine intended for use
on wild raccoons. In this case, genetic engineering was used to construct a "hybrid"
virus made up of a component of the rabies virus inserted into an unrelated
"carrier" virus. The resulting virus confers immunity to rabies but poses no danger
of causing the disease. Baits laced with the vaccine have been distributed in many
parts of the eastern United States in attempts to combat rabies in wild raccoon
populations. The vaccine has been approved by the U.S. Department of Agriculture,
despite suspicions that it has been only marginally, if at all, effective. Early studies
on efficacy failed to demonstrate that the product could control rabies in wild
raccoon populations. Data from more recent studies are being withheld from the
public as confidential business information.
Vaccines
Oral vaccines have been in the works for many years as a possible solution to the
spread of disease in underdeveloped countries, where costs are prohibitive to
producing the proteins, the program was shelved when scientists couldn't figure out
how to spin them into fibers like spiders do. By 2005, the goats were up for sale to
anyone who would take them. While it seems the spider silk idea has been put on
the shelf for the time-being, it is a technology that is sure to appear again in the
future, once more information is gathered on how the silks are woven.